ALEC - Alector Operating profit before deduction of amortization
Alector, Inc. is managed by experienced scientists who ensure transparency in neuroimmunological research and effective fundraising. The brand's high authority in treating Alzheimer's disease inspires confidence within the global community. The EBITDA trend on the GURU.Markets chart demonstrates financial resilience, where 50.79 indicates the level of this metric. Cost optimization is achieved through the flexible delegation of global trials to leading CRO providers.
Alector - analytical breakdowns and key metrics (ALEC)
- market value and analyst target forecast:
- market capitalization statistics:
- shareholders' equity book value data:
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Alector, Inc.|ALEC - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Alector Inc.|ALEC - Company Aggregate Debts|Debts to Net Assets Alector|ALEC - Company Long-Term Debt|Company Short-Term Indebtedness Alector|Quick Liquidity Indicator alector.com
- financial results and valuation multiples details:
ALEC - Net Income|Company Profit Forecast Alector, Inc.|ALEC - P/E Multiple|Forward P/E Multiple Alector Inc.|ALEC - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alector|ALEC - Operating profit EBITDA|Net earnings per one share for the last twelve months Alector|ALEC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months alector.com|ALEC - Earnings per share growth in current year|Projected earnings per share growth rate for next year Alector, Inc.
Summary company analytics:ALEC Alector, Inc.
This metric measures the business's ability to generate cash flow from core operations before deducting financial expenses and depreciation, determining the actual efficiency of the operating cycle. The current change in EBITDA at 50.79 reflects the financial stability of Alector, Inc. (ALEC), which correlates directly with the results of Alzheimer's therapy clinical trials and the quality of strategic engagement with major pharmaceutical partners.
Competitors of Alector, Inc. (ALEC)
Biogen Idec (BIIB) - Profit before interest, taxes and amortization|Neurocrine Biosciences - Operating profit EBITDA|regencellbioscience.com (RGC) - Operating profit before deduction of amortization|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|ACAD: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|Biohaven Pharmaceutical - Operating profit EBITDA|Operating income before deduction of amortization Amylyx Corp AMLX|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PRAX|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit before deduction of amortization CeriBell Inc (CBLL)|Operating profit before deduction of amortization PRTA (Prothena Corp)|Operating income before deduction of amortization Annexon Biosciences Inc.|Operating profit EBITDA OMER (Omeros)|Operating profit EBITDA neurogene.com NGNE|ACIU - Profit before payment of interest, taxes and amortization|VYGR: Profit before payment of interest, taxes and amortization|NMRA: Operating profit EBITDA|Profit before interest, taxes and amortization Scilex Holding Company, Inc. (SCLX)|TVGN (Tevogen Bio Holdings) - Operating profit EBITDA|Operating profit before deduction of amortization Alpha Cognition Corp (ACOG)|Profit before payment of interest, taxes and amortization Cognition Therapeutics, Inc. (CGTX)|Inhibikase Therapeutics Inc - Operating profit before amortization|Operating profit EBITDA SAVA (Cassava)|Assertio Holdings (ASRT) - Profit before interest, taxes and amortization|COYA: Operating profit before deduction of amortization|VTGN - Operating profit EBITDA|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|Acumen Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization CervoMed Inc|Profit before interest, taxes and amortization Alterity Therapeutics Ltd ATHE|Operating profit EBITDA CLNN|Operating profit EBITDA pepgen.com (PEPG)|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|Relmada Therapeutics Inc - Profit before payment of interest, taxes and amortization|Annovis Bio Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Grace Therapeutics, Inc.|AIFF: Operating profit EBITDA|Operating profit before deduction of amortization Klotho Neurosciences|Operating profit before deduction of amortization NRSN|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Income before deduction of interest, taxes and amortization PASG|NEUP: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization NERV (Minerva Neurosciences Inc)|ATHA: Operating profit EBITDA|ADXN - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Operating profit before amortization CYCN (Cyclerion)|Operating profit EBITDA PTIX|Operating profit before deduction of amortization pasitheaclinics.com KTTA|Cortigent - Operating profit before deduction of amortization|Operating income before deduction of amortization Avenue Therapeutics Inc (ATXI)|Brainstorm Cell - Operating profit EBITDA|CARA - Operating profit EBITDA|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|ELYM (Eliem Therapeutics Inc.) - Profit before payment of interest, taxes and amortization|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Longboard LBPH|Operating profit EBITDA MRNS|Operating profit before deduction of amortization nkgenbiotech.com NKGN|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|SAGE: Operating profit before amortization|Neurotrope - Operating profit EBITDA|Profit before interest, taxes and amortization Trevena Inc|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|anewmeds.com (WENA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
